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ABSTRACT
Essential cellular processes such as cell motility, cell migration and
endocytosis/exocytosis require a dynamic actin cytoskeleton.

Actin filaments (F-

actin) polymerize and depolymerize into monomeric actin (G-actin) in response to
signals from the environment. Several different signaling pathways lead to changes
in the actin cytoskeleton (e.g. Rac, RhoA, Cdc42).

Cyclase Associated Proteins

(CAPs) interact with monomeric actin and are conserved in many species. Humans
have two CAP genes, CAP1 and CAP2. Previous studies have demonstrated a role
for CAPs in regulating the actin cytoskeleton and a role in endocytosis/exocytosis
through sequestration of actin monomers.

The objective of this study was to

determine the localization and regulation of human CAP2. Subcellular fractionation
of transfected human embryonic kidney cells (HEK293) indicated CAP2 is a
cytosolic protein with some perinuclear localization.

Immunocytochemistry

confirmed that endogenous CAP2 is cytosolic in rat embryo fibroblasts (REF52).
Cell wounding assays in REF52 cells demonstrated that endogenous CAP2 is
mobilized to the leading edge of cell migration where the actin cytoskeleton is being
remodeled. An in vivo phosphorylation assay in HEK293 cells revealed that CAP2 is
phosphorylated. Deletion and site directed mutagenesis mutants were constructed and
immunoprecipitation reactions were performed with wild type and mutant HA epitope
tagged CAP2. Results revealed that phosphorylation of two conserved serines of
CAP2 are important for the interaction between CAP2 and monomeric actin.
However, phosphorylation was not abolished in a CAP2AA mutant containing
alanine residues substituted for the conserved serine doublet. Therefore it can be
postulated that CAP2 is phosphorylated on multiple residues. Two-dimensional gel
iii
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electrophoresis suggests multiple phosphorylated forms of CAP2 exist. A mutant of
CAP2 (CAP2N433) missing part of the second dimerization domain is hyperphosphorylated,
autoinhibition.

suggesting

CAP2

phosphorylation

may

be

regulated

by

Treatment of serum starved HEK293 cells with PM A, a PKC

activator, caused a large increase in CAP2 phosphorylation. Immunocytochemistry
of PMA treated REF52s demonstrated a redistribution of CAP2 to F-actin-containing
lamellipodial extensions. This suggests the PKC is one of the signaling molecules
involved in the pathway leading to CAP2 phosphorylation. These results support the
role of CAP2 providing a link between cell signaling and regulating actin dynamics.

iv
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CHAPTER ONE
Introduction

The goal of cytoskeletal research is to identify molecules that link the external
signals a cell receives to the cytoskeletal changes that result.

Essential cellular

processes such as cell motility, division, exocytosis and endocytosis are carried out by
rearrangements of the cellular cytoskeleton. The cytoskeleton is a complex of several
scaffolding proteins including tubulin, intermediate filaments, and actin.

Actin is

present in the cell in both a monomeric form, called G-actin, and a filamentous form,
called F-actin. A large number of proteins can interact with actin, some bind G-actin
while others interact with F-actin filaments. A family of proteins that interact with Gactin are cyclase associated proteins (CAPs).

Actin interacting proteins have a

variety of functions including inhibiting or promoting F-actin formation from G-actin
(actin polymerization), altering the rate of actin monomer addition or loss and
sequestering monomeric actin to decrease the concentration of monomer at ends of
the filament (Pollard and' Cooper, 1986). They can also control the affinity of the
monomer for ATP/ADP (ATP monomers are more easily polymerized), capping or
severing and crosslinking of actin filaments (dos Remedios et al., 2003). In addition,
actin-associated proteins are working simultaneously and may interact with each
other or with other regulatory/signaling molecules.

CAP is a monomeric actin

binding protein that has a negative effect on actin polymerization (Freeman et al.,
1995).

The cytoskeleton is a common target of dangerous bacterial pathogens like

Yersinia and Listeria (Gruenheid and Finlay, 2003).

Further understanding of

cytoskeletal proteins like CAP may provide a new defense against this type of

1
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infection. Research on cytoskeletal diseases such as W iscott Aldrich Syndrome may
also benefit from such discoveries. Understanding the role of CAP2 in cytoskeletal
signaling will provide a basis for studying all signaling proteins that cause
cytoskeletal changes.

Yeast CAP
CAP was originally identified by two separate groups of scientists using
different methods.

A 70kDa protein that complexed with adenylyl cyclase in the

yeast Saccharomyces cerevisiae was discovered and named CAP (Field et al., 1988).
At the same time CAP was identified as a protein that suppressed the heat-shock
sensitivity of cells containing an activated Ras2VaI~19 allele in the same yeast. Yeast
CAP was also termed Srv2 for suppressor of Ras valine (Fedor-Chaiken et al., 1990).
In yeast, the Ras2 signaling pathway activates adenylyl cyclase (AC), which
generates cyclic AMP (cAMP). It was originally thought that CAP was regulating
this pathway by interacting with adenylyl cyclase or with Ras itself. Therefore the
earliest theory of CAP function implied CAP was a signaling molecule. Phenotypes
found in CAP deficient (cap) yeast cells included an inability to grow on rich media,
temperature sensitivity,

sensitivity to nitrogen

starvation and abnormal cell

morphology (Field et al., 1990). These phenotypes suggested CAP may be involved
in other processes than signaling, such as cytoskeletal structure. In 1991, the idea that
CAP is a bifunctional protein was proposed by assigning the phenotypes described
above to specific regions of CAP (Gerst et al., 1991). The carboxyl (C) terminus is
able to suppress morphological abnormality, temperature sensitivity, nitrogen
starvation sensitivity and an inability to grow on rich media, while the amino (N)
2
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terminus is required to suppress the heat shock sensitivity (Gerst et al., 1991;
Goldschmidt-Clermont and Janmey, 1991).
In order to determine the precise function of the C terminus o f CAP, this
region was deleted and a search for other genes that could complement its function
was performed.

Profilin was capable of suppressing C-terminal deletion of CAP

(Vojtek et al., 1991). Profilin binds G-actin and decreases its ability to polymerize
into F-actin by decreasing its affinity for ATP. This research suggested that CAP is
not just a regulator of AC in yeast but perhaps also a regulator of cytoskeletal events.
SNC1, a yeast homolog of a mammalian endocytic protein, synaptobrevin, was also
found to suppress loss of C-terminal CAP functions (Gerst et al., 1992). In mammals
synaptobrevins are associated with trafficking of synaptic vesicles, a process that
involves cytoskeletal rearrangement. This research implied that CAP may be playing
a role in endocytosis, perhaps by modifying the cytoskeleton. It appears that CAP is
a multi-functional protein with roles in cytoskeletal events, AC signaling, and in
endocytosis.
In 1995 it was demonstrated that CAP was able to bind monomeric actin and
that this function required the C terminus (Freeman et al., 1995). Since actin is an
essential cytoskeletal protein, this result reinforced the theory that CAP is involved in
regulating cell shape.

It is thought that CAP prevents actin polymerization by

sequestering actin monomers.
When CAP was first sequenced, a centrally located stretch of proline residues
was noted (Fedor-Chaiken et al., 1990). A purpose for the poly-proline region was
identified when Src-homology domains were understood. This region of repeating
proline residues is homologous to the c-Src proto-oncogene and is a binding site for
3
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proteins containing an SH3 (Src homology 3) domain. It has been proposed that the
SH3 binding domain could be a docking site for a protein that regulates CAPs’ ability
to bind actin.

Actin-binding protein 1 (A bplp) was a strong candidate for this

regulatory role since it was shown that an interaction between the SH3 domain of
A bplp and CAP occurred in vitro (Freeman et al., 1996; Lila and Drubin, 1997).
'However, an interaction between full length A bpl and CAP has never been shown. It
was also determined that the SH3 binding domain is required for localizing CAP to
cortical actin patches (Lila and Drubin, 1997).

A region in the N terminus was

identified as being able to regulate binding of SH3 proteins to the SH3 binding
domain (Yu et al., 1999). Perhaps this SH3 interaction is triggered by a signaling
cascade to regulate CAP localization or its ability to bind actin.
Yeast CAP contains two poly-proline regions denoted P I and P2. PI is well
conserved in CAPs of other species while P2 is not (Hubberstey and Mottillo, 2002).
Fragments of CAP smaller than sixty amino acids in length, containing P I and/or P2
were used in a GST pull-down assay to identify interacting proteins (Yanagihara et
al., 1997). Elongation factor l a (E lf-la) and ribosomal protein L3 (RpL3) bound to
residues 308-368 of CAP (contains P2) but not to full length CAP missing the P2
region. No interaction between E lf-la or RpL3 and wild type CAP was shown to
verify this interaction. It is unlikely that those results will provide useful insight into
the function of CAPs as the P2 region is not well conserved among CAPs.

Non-Yeast CAPs
Seventeen CAPs have been sequenced in fourteen different species.

The

majority of research performed has focused on yeast CAP, Srv2, due to the simplicity
4
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of the yeast system.

Yeast molecular work has provided an excellent basis for

understanding CAPs of other species as the central and N terminal domains are well
conserved through different species.
CAP homologues have been identified in two plant species, Gossypium
hirsutum (cotton) and Arabidopsis (a member of the mustard family) (Barrero et al.,
2002; Kawai et al., 1998). Cotton fibers begin life as single cells that elongate over
1000 times their diameter very early in development. Cotton CAP (GhCAP) was
found to be expressed mainly in these young fibers undergoing elongation (Kawai et
al., 1998). When expressed in yeast, Arabidopsis CAP1 (AtCAPl) was able to rescue
the abnormal cell morphology and random budding phenotype from cap' cells.
AtCAPl was able to bind actin both in vitro and in vivo. Overexpression of AtCAPl
in transgenic plants lead to a reduction in cell size and number causing growth
abnormalities.

Tobacco suspension culture cells expressing AtCAPl displayed

abnormal F-actin and an inability to undergo mitosis (Barrero et al., 2002).

This

research suggests CAP’s role in plants is associated with cell elongation and division.
Similar to AtCAP, mushroom CAP (Lentinus edodes) can complement C terminal
CAP deletions and can bind S. pombe actin in a yeast two hybrid test (Zhou et al.,
1998).
In Dictyostelium discoideum, CAP binds G-actin in a calcium independant
manner (Gottwald et al., 1996). The C terminal of Dictyostelium CAP (DdCAP) can
sequester twice as much actin as full length DdCAP (Gottwald et al., 1996).
Interestingly,

phosphatidylinositol-4,5-bisphosphate

(PIP2)

can

prevent

the

interaction between CAP and actin in this species (Gottwald et al., 1996; Noegel et
al., 1999). This form of regulation has not been shown with any other CAP. DdCAP
5
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is a cytoplasmic protein but localizes to the leading edge of migrating cells (Gottwald
et al., 1996).
Chlorohydra viridissima CAP homologue, CvCAP, is thought to be a
signaling protein. In Chlorohydra there is a signaling pathway that effects nerve-cell
determination and differentiation. When the proper agonist binds a transmembrane
receptor called head activator (HA), cAMP is generated.

CAP antisense

oligonucleotides were able to block this pathway upstream o f cAMP production
(Fenger et al., 1994). This suggests CvCAP is playing a role in transducing a signal
from HA to adenylyl cyclase (AC is the enzyme that generates cAMP).

It is not

known if CAP binds HA or AC in this cascade. In fact CAP has not been shown to
interact with AC in any species other than yeast.
Porcine CAP, Actin Sequestering Protein 56 (ASP-56), was the first non-yeast
homolog discovered.

ASP-56 has been shown to bind actin in vitro with 1:1

stoichiometry and is unable to generate sites of actin nucleation (Gieselmann and
Mann, 1992).

This paper was the first to show CAPs’ ability to bind actin, which

was essential to learning more about CAP function with respect to the cytoskeleton.
CAP has recently been identified in Xenopus laevis, the African frog, where
XCAP1 expression is developmentally regulated (KhosrowShahian et al., 2002).
XCAP1 is highly expressed in the developing eye, specifically in the lens where actin
dynamics are essential for proper development.

Also, XCAP2 has been isolated

(unpublished results). Capulet or Act up, the Drosophila homolog of CAP (DmCAP)
is also expressed in the eye (Benlali et al., 2000). During development, within the
eye disc, cells rapidly and drastically alter their shape prior to neuronal
differentiation.

DmCAP is essential for this shape changing process in Drosphila

6
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(Benlali et al., 2000). DmCAP inhibits actin polymerization within the eye disc to
prevent F-actin accumulation.

At the same time, profilin, another actin-binding

protein, is acting antagonistically and encouraging actin polymerization.

This

suggests that actin binding proteins, including CAP, are essential to cellular processes
that require shape changes, such as development. At the same time another group of
scientists discovered DmCAP to be involved in cell polarity (Baum et al., 2000).
Mutants deficient in CAP were unable to establish proper anterior-posterior and
dorsal-ventral axes during oocyte development. This process involves dynamic actin
and microtubule cytoskeletons.

This research suggests that CAP plays a role in

generation of polarity through its relationship with the actin cytoskeleton.
Wills et. al. discovered that DmCAP collaborates with the proto oncogene cabl in Drosophila S3 cells (Wills et al., 2002).

This collaboration was generated

using full length DmCAP and small fragment of c-abl containing only its SH3
domain. W ithout demonstration of an in vivo interaction between full length c-abl
and CAP, it is still premature to conclusively correlate a role for CAP in signaling
with c-abl.
Recently, an RNA interference (RNAi) experiment was performed on over 90
proteins thought to be involved in actin dynamics (Rogers et al., 2003). Drosophila
S2 cells were treated with RNAi for 7 days, then plated on glass coverslips coated
with concavalin A.

W ild type cells will attach and spread within thirty minutes.

Cells treated with DmCAP 1 RNAi did not form lamellipodia and therefore failed to
spread. Within these cells, F-actin was diffusely localized which was altered from the
pattern of stress fibers present in wild type cells. Cofilin RNAi treatment presented
the identical morphology.

This is interesting because cofilin is an actin binding
7
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protein thought to act in concert with CAP (Moriyama and Yahara, 2002).

In

addition, inhibition of each of these proteins also resulted in cytokinesis defects
(Rogers et al., 2003). Since CAP is thought to play a role in cell migration and actin
dynamics these results are not surprising but it would be interesting to see if similar
results are achieved in mammalian cells with two CAP homologs present.
In both mouse and rat, two homologues of CAP have been sequenced (Vojtek
and Cooper, 1993; Zelicof et al., 1993). CAP1 appears to be expressed in all tissue
types at varying levels while CAP2 has more restricted expression (Swiston et al.,
1995; Vojtek and Cooper, 1993; Zelicof et al., 1993). Perhaps these differences in
expression represent different functional roles of CAP1 and CAP2. Mouse CAP1 has
been seen to localize to the leading edge of growing 10T1/2 mouse fibroblasts,
supporting a role for CAP1 in cytoskeletal rearrangement (Vojtek and Cooper, 1993).
The presence of two CAP homologues in all vertebrates studied suggests that these
two proteins may have evolved different functions in response to increasing
developmental complexity.

Signaling and the Actin Cytoskeleton
In the yeast S.cerevisiae, Ras activation induces cytoskeletal changes through
activation of adenylyl cyclase (AC). Yeast CAP, Srv2, binds AC as a contributing
member of this pathway (Fedor-Chaiken et al., 1990; Field et al., 1988). Although
the AC binding domain is partially conserved in all CAPs, this particular signaling
function has not been demonstrated in higher vertebrates. Perhaps mammalian CAPs
are involved in a pathway that does not include AC.

8
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Three members of the Rho family of small GTPases, Rac, RhoA, and Cdc42,
have been implicated in signaling pathways leading to cytoskeletal changes in a
variety of mammalian cell types (for review see Hall, 1998). In Swiss 3T3 fibroblasts
each of these GTPases has a very specific effect. Upon activation by platelet-derived
growth factor (PDGF), Rac causes the assembly of lamellipodia. Lamellipodia are
pleat shaped protrusions at the cell periphery (Symons, 1996). Rho can be activated
by lysophosphatitic acid and this leads to actin stress fiber and focal adhesion
formation.

Filopodia, or thin finger-like extensions at the cell membrane, are

generated by Cdc42 activation. There is crosstalk between the three GTPases, by
which they can activate or suppress each other. Allen et. al. examined macrophage
chemotaxis and determined only Rho and Rac are required for cell migration,
suggesting Cdc42 is required for direction of migration but not force (Allen et al.,
1998). Rac, Rho, and Cdc42 are the most commonly studied cytoskeletal regulators
but it is likely that there are additional signaling molecules regulating cytoskeletal
dynamics.

Role of CAP in cell elongation, development and cell migration
Cell Elongation
Cell elongation is a process that is essential for motility in single cell
organisms like yeast. In multicellular organisms cell elongation is involved not only
in mitosis but in growth, development, and differentiation. Xenopus CAP1 is highly
expressed in the developing eye (KhosrowShahian et al., 2002).
differentiation

requires

rapid

cytoskeletal

changes

that

Verbrate eye

CAP-assisted

actin

polymerization may provide. In order to form the lens, cells at the posterior of the
9
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eye lose their nuclei and elongate to create the primary lens fibers (KhosrowShahian
et al., 2002).

Since CAP1 is expressed in the eye during this stage of Xenopus

development, it has been suggested that CAP1 plays a role in cell elongation.
The yeast Canadida albicans, is able to change form between budding and
filamentous or hyphal growth, during its life cycle.

C. albicans can form both a

pseudohyphal and a true hyphal form. Pseudohyphae are cells that continue to bud
but never separate, a type of cell elongation.

Transitions between these forms is

controlled by various signaling pathways and cAMP levels (Bahn and Sundstrom,
2001). A C. albicans strain deficient in CAP1 displayed decreased cAMP levels and
was unable to perform bud-hyphal transitions or filamentous growth (Bahn and
Sundstrom, 2001). CaCAPl was able to regulate these bud hyphal transitions perhaps
by controlling intracellular cAMP levels through its relationship with adenylyl
cyclase. This experiment suggests CAP1 plays a functional role in cell elongation in
yeast.
When cotton CAP, GhCAP, was first identified it was noted that GhCAP was
mainly expressed in young fibers (Kawai et al., 1998). A cotton fiber consists of a
single cell that has elongated immensely during development, but has never divided.
This result suggests CAP is present in young fibers because it assists in the process of
cell elongation, which is performed extensively in young fibers.
Recently, Arabidopsis CAP1 (AtCAPl) was overexpressed in transgenic
plants and this led to phenotypes that could imply a defect in cell elongation (Barrero
et al., 2002). These plants had smaller leaves and stems but normal length of the
main root.

Further analysis revealed that cell number was reduced.

A tCA Pl

overexpression in tobacco suspension cells caused inhibition of mitosis and loss of
10
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actin filaments.

Both mitosis and leaf growth require cell elongation using actin

polymerization. Abberant expression of AtCAPl causes defects in cell elongation.
Therefore A tCA Pl may play a role in the actin dynamics associated with cell
elongation.
Development

CAPs role in development is not well understood but a few studies have
attempted to clarify its function. In Xenopus, CAP1 expression is upregulated before
gastrulation and it localizes specifically to head mesenchyme, lens, otic vesicle and
trunk mesoderm (KhosrowShahian et al., 2002).

XCAP1 is a developmentally

regulated gene as its expression levels vary at different stages of Xenopus
development.

XCAP1 expression in the developing eye is similar to Drosophila

CAP, which is expressed in the eye disc (Benlali et al., 2000). During Drosophila
development, as well as in most vertebrates, anterior-posterior and dorsal-ventral axes
are generated within the oocyte (Baum et al., 2000). These axes create polarity for
the developing organism.

DmCAP accumulates within the oocyte to inhibit actin

polymerization in order to assist in generating poles. CAP deficient mutants do not
establish correct polarity (Baum et al., 2000).

Areas within organisms that are

undergoing early development experience rapid and drastic cell shape changes. The
cellular cytoskeleton is activated via signaling pathways to produce specific
cytoskeletal dynamics. Since CAP is present in these specific developing areas in
Xenopus and Drosphila, perhaps CAP aids in developmental cytoskeletal dynamics or
signaling in other species.

11
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Cell Migration

When scientists began to examine mammalian CAPs, a new role for CAP was
discovered. Mouse CAP1 (mCAPl) transfected into mouse fibroblasts was localized
to the leading edge of migrating cells (Vojtek and Cooper, 1993). Although this was
not endogenous m CA Pl expression, it was not alarming to see a known actin binding
cytoskeletal protein present at a site of actin remodeling. The result could not be
obtained in yeast as they are unicellular organisms. Mammalian cell migration is
similar to the movement of cells during development, yeast cells cannot initiate this
type of movement.

Drosophila S2 cells were treated with DmCAP antisense for

seven days then examined for morphological defects (Rogers et al., 2003). S2 cells
deficient in CAP were unable to migrate and therefore failed to spread after plating
and had defects in cytokinesis.

This research reinforces a role for CAP in cell

migration and cell division.

Mammalian CAPs and Protein Interactions
Mammals have two homologs of CAP with very similar domain structure
(Figure 1) but different patterns of expression. In rat, CAP1 is expressed highly in
spleen, testes, and lung while CAP2 is only highly expressed in testes, low in lung
and undetectable in spleen (Swiston et al., 1995). mCAPl has similar expression
patterns as rat CAP1 (Swiston et al., 1995; Vojtek and Cooper, 1993) but CAP2
expression in mouse and CAP1 and CAP2 expression in humans has not been
published. Human, mouse and rat CAP1 have over 90% amino acid identity but have

12
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Adenylyl cyclase
binding domain
RLE

Poly-proline
region
PI

V

Actin binding
domain

P2

D1

D2

Figure 1: Common Domains o f Cyclase Associated Proteins. This diagram is
representative of the functional domains of CAP. Yeast CAP is used here as an
example. CAPs contain several domains that have been conserved from yeast to
mammals with the exception of the second poly-proline region (P2), which is not well
conserved. A verprolin homology region is present between the two poly-proline
regions. D1 and D2 represent the N and C terminal dimerization domains,
respectively. The N terminal Adenylyl cyclase binding domain contains both a
dimerization domain (D l) and the RLE motif. The C terminal actin binding domain
encompasses D2.
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less than 40% identity with yeast CAP, Srv2 (for review see Hubberstey and Mottillo
2002).

Human CAP1 and CAP2 have 64% amino acid identity with greater

homology in the central and C terminal domains (Yu et al., 1994). The distinctive
expression patterns of rC A Pl and rCAP2 and the decrease in amino acid identity
from 97% between hC A Pl and m CAPl to 64% between hCA Pl and hCAP2,
suggests that these two homologues may play different roles in mammals
(Hubberstey and Mottillo, 2002).
CAPs contain several interactive domains including two dimerization
domains, one or two poly-proline regions, and an actin binding domain.
terminal dimerization domain is also called the RLE or CAP motif.

The N

This motif

contains the amino acids RLE repeated twice and is thought to form an amphipathic
helix which may participate in protein-protein interactions (Cohen and Parry, 1990).
Recently, the N terminus o f Dictyostelium CAP was crystallized (Ksiazek et al.,
2003). The overall structure is an alpha helix composed of six antiparallel helices
which may serve to form multimers with other CAPs. rCA Pl has been shown to
dimerize via a yeast two hybrid assay, and this interaction did not require P I or P2
(Zelicof et al., 1996). m C A Pl interacts with itself and its N or C terminal deletions
(Hubberstey et al., 1996).

An interaction between the N and C terminal mCAPl

fragments demonstrates the use of both dimerization domains (Hubberstey et al.,
1996). m CAPl has been shown to interact with its homologue mCAP2 and BAT3, a
nuclear protein via yeast two-hybrid and in vitro immunoprecipitations of epitope
tagged proteins (Hubberstey et al., 1996; Manchen and Hubberstey, 2001; Thress et
al., 1998).

The functional significance of the interaction between CAP and BAT3 is

still unknown. m CAPl and hCAP2 interact with endogenous actin from yeast extract
14
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or NIH 3T3 cell lysate (Hubberstey et al., 1996).

This plethora of interaction

information indicates CAP’s inclination for oligomerization. Perhaps CAP can form
large complexes with itself and/or other interacting protein to sequester monomeric
actin.

Throughout the vast literature pertaining to human CAP and its homologues,
the names of actin, cofilin, actin binding protein (A bpl) and others are heard
frequently. While CAPs’ interaction with actin is well accepted, it relation to cofilin
is non-physical. Cofilin is able to enhance the treadmilling o f actin filaments to aid in
motility (Carlier et al., 1997). Actin based motility relies on the elongation of actin
filaments in a single direction. Actin monomers are released from the pointed end of
the F-actin filament and cofilin aids in their rapid release. When the actin-cofilin
complex was purified from cell extracts, CAP1 and A ipl (actin interacting protein 1)
were found in high abundance (Moriyama and Yahara, 2002). Moriyama theorizes
that A ipl helps cofilin bind F-actin while CAP1 assists in the removal o f actin
monomers. This is quite possible considering CAPs ability to bind G-actin and its
presence at sites of actin rearrangement in Dictyostelium and mouse (Gottwald et al.,
1996; Vojtek and Cooper, 1993). In addition, it was found that CAP1 was able to
increase nucleotide exchange on G-actin.

G-actin is released from F-actin in its

inactive ADP-actin form and polymerized in its active ATP-actin form.

Another

actin-binding protein, profilin, promotes nucleotide exchange from ADP to ATP on
freshly released actin monomers (Goldschmidt-Clermont and Janmey, 1991; Vinson
et al., 1998).

It is interesting to note that profilin can compensate for C terminal

15

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

deletion of CAP in yeast (Vojtek et al., 1991), suggesting a functional linkage
between these two proteins.
While cofilin and profilin link CAP to cytoskeletal events involving actin,
A bpl suggests a role for CAP in SH3 binding interaction and potential signaling
activities.

Although CAPs are clearly multifunctional proteins, the regulation of

CAPs, especially mammalian CAPs, is virtually unknown.

The role of CAP in endocytosis
It is practical that the actin cytoskeleton is involved in a process like
endocytosis.

Endocytosis involves four steps: invagination of the cell membrane,

formation of coated pit, associated o f molecules with coated pit, and detachment of
the vesicle (for review see (Qualmann et al., 2000). Each of these steps could be
enhanced or inhibited by actin polymerization. Actin binding proteins could assist in
actin remodelling to promote endocytosis.
The first indication that CAP may function in endocytosis came from
experiments with yeast CAP.

It was found that SNC1, a yeast synaptobrevin

homologue, could suppress the morphological defects caused by the loss of the C
terminal of CAP in S.cerevisiae (Gerst et al., 1992). Synaptobrevins are known to be
involved in targeting and fusion of synaptic vesicles (Elferink et al., 1989; Sudhof et
al., 1989).

SNC1 deletion causes no phenotype in yeast, likely due to genetic

redundancy. If synaptobrevin can complement CAP function than perhaps CAP plays
a role in endocytosis.

A yeast temperature sensitive endocytosis mutant was

identified as having a defect in a gene called Sla2 (Wesp et al., 1997). Sla2 contains a
coiled-coil domain that is required for its endocytic function.

In addition, Sla2
16
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deficient yeast cells are viable unless they are also deficient in Srv2 or A bpl
(synthetic lethal with Srv2, A bpl) (Wesp et al., 1997). A mutant of CAP defective
for endocytosis called End4p was also identified in this study. This suggests that
CAP performs a redundant role in endocytosis perhaps through a protein-protein
interaction via its coiled-coil domain.
Endocytic function also has also been suggested for A bpl. A bpl is able to
bind to the SH3 domain of Rvsl67p, a homolog of mammalian amphiphysin (Lila
and Drubin, 1997). Amphiyphysin is a synaptic vesicle associated protein that has a
role in endocytosis at the synapse (Wigge and McMahon, 1998). As mentioned, the
poly-proline region of CAP has been shown to collaborate with the SH3 domain of
Abpl (Freeman et al., 1996). If CAP interacts with A bpl, an endocytic protein, CAP
may be a regulator of endocytosis itself.
Recently, CAP2 was isolated in a complex with synaptotagmin VII and A bpl
(Fukuda et al., 2002). The family of synaptotagmin proteins are thought to regulate
vesicle trafficking, an integral function of endocytosis (Marqueze et al., 2000). An
actual interaction between full-length CAP2 and synaptotagmin or A bpl was not
shown.

This implies that CAP2 like its homolog CAP1 may play a role in

endocytosis by interacting with other endocytic proteins.

Protein Regulation
Little may be known about CAP regulation but other mammalian actininteracting proteins, such as Wisckott Aldrich Syndrome protein (WASp), have been
well explored. W ASp is a regulator of actin cytoskeletal dynamics that is able to
initiate and increase the rate of actin polymerization (Machesky and Insall, 1999).
17
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When WASp is activated it creates an actin nucleation center by encouraging the
formation and activation of a seven protein complex called the Arp2/3 complex.
Once this complex is activated it becomes an actin nucleation center, a site of rapid
actin polymerization (Machesky and Insall, 1999). Actin is rapidly polymerized or
depolymerized when a cell needs to change shape or move (Hall, 1998). If WASp
were constitutively active the cell would be extremely rigid and unable to move.
The ability of WASp to activate the Arp2/3 complex is controlled by several
complex mechanisms (reviewed by(Kim et al., 2000; Zigmond, 2000).

WASp

contains interactive domains that allow the protein to fold over on itself creating an
autoinhibitory loop. This inhibited or bent conformation cannot activate the bound
Arp2/3 complex thus preventing actin polymerization.

When the small GTPase,

Cdc42, binds to the inhibited form of WASp, the protein can unfold and activate the
Arp2/3 complex. Recent data has demonstrated that phosphorylation of WASp on
tyrosine 291 by Hck (a Src family kinase) enhances the activation of the Arp2/3
complex, increasing actin polymerization (Cory et al., 2002). Essentially WASp uses
both autoinhibition and phosphorylation to control its ability to activate actin
polymerization. It is interesting to hypothetheize that CAP2 may be regulated in a
similar fashion as WASp.

Like WASp, CAP2 is a G-actin binding protein that

contains two dimerization domains that interact with each other.

It was unknown

whether CAPs are phosphorylated however, most CAPs contain two serine residues at
positions 433 and 434 (Figure 2) that may constitute sites of phosphorylation.
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Figure 2: Conserved Residues in the CAPs. The two sequential serines in
positions 433 and 434 (for hCAP2) are highly conserved throughout all CAPs.
Eleven out of fourteen CAPs shown in this figure have both serines. Those that do
not have a second serine contain a threonine residue in its position. LentinulaCAP
has a cysteine residue but this is a likely sequencing error and may be a serine
residue. (Figure was borrowed with permission from Hubberstey and Mottillo 2002)
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Thesis Objectives
Very little is known about mammalian CAP2 as previous research has focused
primarily on CAP1. Research on yeast CAP is more extensive than the work done
with mammalian CAPs.

It is thought that mammalian CAP1 is involved in

cytoskeletal remodeling since mouse CAP1 was found to localize to the leading edge
in migrating cells. The subcellular localization of human CAP2 is unknown. Little is
known about the regulation of mammalian CAPs.

It is known that yeast CAP is

involved in a Ras signaling pathway via its interaction with adenylyl cyclase. Since
mammalian CAPs do not interact with adenylyl cyclase it is unlikely that they are
involved in a similar pathway. Regulatory mechanisms involving post-translational
modifications of CAP have not been identified. Previous research indicates CAP2 is
phosphorylated in vivo. Determining the functional significance of phosphorylation
of human CAP2 is the underlying goal of this study. The following specific issues
were addressed:
1. Determine the subcellular localization of human CAP2
2. Determine if CAP2 localization changes upon actin rearrangement
3. Confirm that CAP2 phosphorylated in vivo
4. Identify the phosphorylated residues of CAP2
5. Identify the pathway leading to phosphorylation of CAP2
6. Does phosphorylation of CAP2 alter actin binding?
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CHAPTER TWO
Human CAP2 is phosphorylated in vivo in response to PKC activation

Introduction
Multifunctional proteins require strict regulatory mechanisms to ensure that
the specific function is performed at the proper time. Proteins are often controlled by
post-translational

modifications

commonly phosphorylation.

like

ubiquitination,

glycosylation

and

most

Phosphorylation is the reversible addition of a

phosphate group (from ATP) to a serine, threonine or tyrosine residue performed by a
protein kinase. Kinases and phosphatases are activated by an upstream signal that the
cell receives from its external environment. The goal of a signaling cascade is to
relay an external message to induce an internal response.

In addition to post-

translational modifications, proteins can be regulated by other mechanisms like
autoinhibition.
Cytoskeletal changes are a type of internal response to an environmental cue.
The presence of light or food will activate a receptor on the cell surface causing
activation of a signaling cascade that results in actin remodeling to move the cell
towards the stimulus. CAPs are thought to be involved in this complex process as
m CAPl is present at the leading edge in migrating cells (Vojtek and Cooper, 1993).
Yeast CAP signaling is more clearly understood than vertebrate CAP signaling. In
the yeast S.cerevisiae, signaling through Ras2 leads to activation of adenylyl cyclase
(AC), generating cAMP.
pathway.

CAP binds AC in yeast and is thought to regulate this

This pathway regulates cell growth through cytoskeletal changes.

Vertebrate CAPs have not shown interaction with AC and therefore must be involved
21

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

in a different signaling pathway. Signaling in mammals may be more complex than
in yeast and perhaps this is why there are two CAP homologs in mouse, rat and
human.
CAP contains several domains that could relay signals from upstream
effectors and cause cytoskeletal changes. The central poly-proline region could be
utilized to interact with signaling proteins containing SH3 domains. The putative N
terminal coiled coil domain may interact with an upstream regulator or downstream
effector of CAP. Most important is the C terminal actin binding domain of CAP.
This region may be responsible for actin sequestration or release according to specific
environmental cues.

CAPs also contain two highly conserved serine residues at

position 433 and 434 (in human CAP2). Both of these serines are present in 14 of 17
CAPs, and those that do not have a second serine have a threonine residue in its place
(Hubberstey and Mottillo, 2002).

Since these potential phosphorylation sites are

highly conserved, they suggest a regulatory mechanism that may be conserved from
yeast to mammals.
This chapter explores the possible mechanisms of regulation of CAP2,
revealing whether human CAPs are phosphorylated in vivo, and if so, what signaling
pathway may be responsible. Results indicate that CAP2 is phosphorylated at several
sites within the carboxyl terminus including two conserved serine residues (433, 434).
The level of phosphorylation of CAP2 is increased in response to PKC activation by
PMA, a phorbol ester.

PKC is naturally activated by increasing concentrations of

diaceyl glycerol (DAG). PMA is a DAG mimic. Increased phosphorylation upon
treatment with the DAG mimic PMA, suggests that CAP2 is modified by part of a
signal transduction pathway downstream PKC. Remembering that CAP2 is an actin-
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binding protein, these results reinforce the theory that CAP2 is a protein that links
signal transduction (i.e. PKC) to cytoskeletal dynamics (i.e. actin binding). Further
evidence to support this role of CAP2 is that alteration of two conserved serine
residues not only decreases phosphorylation but also reduces actin binding, a major
function of CAP2. Perhaps the ability of CAP2 to bind actin or its affinity for actin is
regulated through phosphorylation induced by PKC activation.

Material and Methods

Molecular Cloning
Full length human CAP2 in pCI-HA was used as template DNA to create the deletion
mutants C232, N304, and N433 (Figure 3A).

Polymerase Chain Reaction (PCR)

using the appropriate primers (listed in Appendix A) was used to generate these
deletion fragments which were then digested with EcoRl and X hol and ligated into
pCI-HA, an HA (influenza hemagglutin protein traffic marker) tagged mammalian
expression vector. All vectors were transformed into E.coli strain D H 5a competent
cells.

Clones were verified through diagnostic restriction digestion and sequence

analysis. Serines 433 and 434 were replaced with alanine residues in the CAP2AA
construct.

CAP2AA was generated using a two-step PCR-mutagenesis method

(Figure 3B). Briefly, in separate PCR reactions primers A and B and primers C and
D were used to generate a large (AB) and a small (CD) fragment of CAP2 containing
the alanine residues in place of serines 433 and 434 (primer sequences in Appendix
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Figure 3A: CAP2 Mutant Constructs. Various CAP2 deletion mutants were
constructed in order to isolate regions of CAP2 phosphorylation. The CAP2N304
fragment was generated via PCR using primers 31 and 109. CAP2C232 was
generated using primers 108 and 32 while CAP2N433 was generated from primers 31
and 161. Each fragment was cut with EcoRl and X hol and ligated into pCI-HA, an
epitope tagged mammalian expression vector.
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Figure 3B: Construction of CAP2AA Mutant. The CAP2AA mutant was
generated to create a mutant of CAP2 lacking two highly conserved serine residues
thought to be potential phosphorylation sites. This was performed using a two-step
PCR process using wild type CAP2 primers A and D (primers 31 and 32) and larger
forward and reverse primers (157 and 158) containing altered nucleotides to create
alanine residues in place of serine residues. The alteration in the nucleotides also
generated a new Hsp90I site that was used as a diagnostic tool.
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A). Primers B and C were designed to generate a new Hsp90I restriction site within
the altered nucleotides.

The large and small fragments were combined with the

forward and reverse CAP2 primers (primers A and B) to create the full length C2AA
DNA fragment.

Once the CAP2AA fragment was cloned into pCI-HA it was

digested with Hsp90I and sequenced to verify the serine to alanine switch.

Cell Culture
Human embryonic kidney cells (HEK293s) were maintained in DMEM (Sigma)
supplemented with 10% fetal bovine serum (FBS) (Sigma) and 100 units/ml
penicillin/streptomycin (Invitrogen/Life Technologies).

Cells were incubated in a

humidified 37°C incubator with 5% CO 2 .

In Vivo Phosphorylation Assay
HEK293 cells were transfected with Lipofectamine 2000 (Invitrogen) in 60mm dishes
using 4pg of each DNA construct, pCI-HACAP2, CAP2C232, CAP2N304,
CAP2N433, or CAP2AA and 6ul Lipofectamine 2000, as per manufacturers
instructions (Invitrogen). 24h post-transfection, cells were washed twice with 2ml
phosphate free DMEM. Media was then replaced with 1ml phosphate free DMEM +
10%FBS and 0.3 pCi/m I orthophosphate (Amersham). Cells were incubated for 3h at
37°C with gentle agitation every 15m to prevent desiccation of the cells. Media was
removed and cells were washed twice with sterile IX PBS. Cells were extracted in
ice-cold 300pl RIPA lysis buffer [20mM TrisOH pH7.5, 150mM NaCl, lOmM KC1,
ImM N aV 04, 50mM NaF2, 1% IGEPAL CA-630 (NP-40), 10% glycerol, and
protease inhibitor (Complete Mini, Roche)]. Cell extracts were briefly sonicated then
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centrifuged

at

15000rpm

for

10m

at 4°C.

Supernatants

were

used

for

immunoprecipitations and protein extract samples.
For the sodium vanadate control lOOpM NaVC>4 was added to radiolabelled
media for the final hour o f incubation. NaVC>4 is a phosphatase inhibitor that was
present in the cell lysis buffer that will prevent dephosphorylation of CAP2 by
phosphatases within the cell extract (Heffetz et al., 1992).
In the case of the alkaline phosphatase treated samples, the washed beads
were resuspended in a total volume of lOOpl with 10X Calf Intestinal Alkaline
Phosphatase buffer containing 20 units of Calf Intestinal Alkaline Phosphatase
(CIAP) and incubated at 30°C for 2h. After incubation, beads were washed twice with
500pl RIPA buffer. CIAP will remove phosphate groups from phosphorylated CAP2
while the protein is attached to the protein A bead.
In the calcium dependency assay, 3mM CaCl2 and 3mM EDTA together or
3mM CaCh alone was given to transfected HEK293s for 16h prior to in vivo
phosphorylation assay.
For the phosphorylation assays involving drug treatment, transfected cells
were serum starved for 16h prior to the addition of radioactive phosphate.

The

radiolabelled media used was also serum free. Drugs were added to the radiolabelled
media when lh of incubation remained.

Drugs were added in the following final

concentrations 2pM PMA, lOpM forskolin, or lpM staurosporine.

In the PMA

dosing experiment the following final concentrations of PMA were used: 0.5pM,
lpM , 3pM, and 5pM.

29

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Antibody-linked Beads
1.5mL of protein A agarose beads (Sigma) and 300pl 12CA5 monoclonal antibody
was resuspended in IX PBS to a final volume of lOmL in a 15mL conical tube. The
tube was gently rocked for 1.5h at room temperature.
3400rpm for 30s.

The beads were spun at

The supernatant was discarded and replaced with lOmL 0.2M

sodium borate pH 9.

Beads were washed with lOmL 0.2M NaBo twice before

adding 20mM dimethylpimelimidate.

The tube was rocked for lh at room

temperature then spun at 3400rpm for 30s.

Supernatant was discarded and beads

were washed once with 0.2 M ethanolamine and then rocked for 2h. Beads were spun
at 3400rpm for 30s and supernatant was discarded. Beads were washed twice with
lOmL IX PBS then resuspended to a final volume of 1.5mL o f bead slurry.

Immunoprecipitation and Western Immunoblotting
Equivalent amounts of radiolabelled protein extracts were mixed with 25pi protein A
agarose beads (Sigma) for 30min in a total volume of 500pl at 4°C. Extracts were
centrifuged at 2500rpm for 30s.

Supernatant was combined with 30pl protein A

beads chemically coupled to monoclonal anti-HA antibody (12CA5) and mixed for
2h at 4°C. Beads were then washed 5x 10m each with 500pl RIPA without glycerol
or protease inhibitors at 4°C. The beads were then boiled in IX sample buffer and
proteins were analyzed via western immunoblot.

Protein extract samples and

immunoprecipitated proteins were resolved on 10% SDS PAGE gels then transferred
to nitrocellulose membranes. Membranes were blocked in 2% skim milk in TTBS
overnight. For the detection of HA-tagged proteins monoclonal 12CA5 antibody and
30

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

secondary horseradish peroxidase conjugated sheep anti-mouse antibodies were used
at dilutions of 1:10,000 and 1:3,000 respectively. For the detection of actin, mouse
anti-actin antibody was used at a dilution of 1:2,000. Protein bands were visualized
using a Lumi Light Chemiluminescence kit (Roche)
instructions.

as per manufacturers

If required, blots were stripped using 20ml Western Restore Buffer

(Pierce) for lh at 37°C with gentle agitation, then reblocked and probed again.
Nitrocellulose membranes containing potentially radiolabelled proteins were rinsed in
distilled water then covered in plastic wrap.

Membranes were mounted into an

autoradiography cassette beneath a sheet of X-ray film (Kodak) and an intensifying
screen (Kodak). The membranes were exposed for a short exposure (24-48h) and a
long exposure (5-7d) at -80°C.

Antibodies
The N-terminal 304 residues of CAP2 were conjugated to GST to create a GST fusion
protein. The purified protein was used to raise a rabbit polyclonal antibody against
CAP2 by Covance Inc. CAP2 antibodies were affinity purified from whole sera using
a CNBr-activated Sepharose 4B column (Ambersham Biosciences) using CAP2 N304
as an antigen. The anti-HA (12CA5) mouse monoclonal antibody was a kind gift
from Dr. Dalian Young (University of Calgary).

Monoclonal mouse anti-actin

antibodies were purchased from Chemicon.

Two-dimensional Gel Electrophoresis
HEK293 cells were transfected with HA-tagged CAP plasmids using Lipofectamine
2000 as per manufacturers instructions. Two 100mm plates of cells were used per
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immunoprecipitation.

Cells were collected in a total volume of 500pl RIPA lysis

buffer for each immunoprecipitation. Immunoprecipitations were carried out in the
same manner as previously described.

After washing, beads were resuspended in

140pl of rehydration buffer (Biorad) and incubated at 37 °C for 15m. This buffer
contains urea and detergent that will dissociate the proteins from the beads and
denature the proteins. Beads were then centrifuged briefly and the supernatant was
pipetted into separate channels on a focusing tray. Immobilized pH gradient (IPTG)
strips of pH range 5-8 (Biorad) were placed gel side down onto the protein samples.
The strips were overlayed with 1ml of mineral oil (Biorad) then incubated for 16h at
room temperature. The proteins, now absorbed into the strips, were focused using
Biorad Isoelectric Focus (IEF) power supply to 10,000-volt hours (approximately
5.5h). Once the proteins were focused on the strips the strips were incubated with
two equilibration buffers (Biorad) for 15m each with gentle agitation. The strips were
inserted gel side forward between two glass plates containing 7% polyacrylamide
gels. Strips were overlayed with prewarmed agarose to prevent air bubbles. Gels
were run at 150V for 45m. Proteins were transferred from gels onto nitrocellulose
membranes using a starting current of 200mA for lhour at 4°C.
immunoblotting was performed as described previously.

Western

HA-CAP2 proteins were

visualized using the anti-CAP2 antibody and the anti-HA antibody.
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Results

CAP2 is phosphorylated in vivo
The fact that several actin binding proteins (e.g. WASp, cofilin) are phosphorylated
led to our hypothesis that CAPs may also be post-translationally modified. Therefore,
HA-tagged CAP2 was overexpressed in HEK293 cells and the phosphorylation status
of CAP2 was determined. The results of an in vivo phosphorylation assay are shown
in Figure 4A.

HA-CAP2 was found to be phosphorylated.

To examine which

regions of the protein contained phosphorylated residues, several HA-CAP2 mutants
were constructed. The CAP2AA mutant has two alanine residues in place of two
highly conserved serine residues at positions 433 and 434. The CAP2N433 mutant is
missing the two conserved serines and the C terminal 41 amino acids. CAP2C232
contains an N terminal deletion of 242 amino acids while CAP2N304 is missing 217
amino acids of the C terminus.
phosphorylated

than

full

The results indicate that HA-CAP2AA is less

length

CAP2

however,

phosphorylated than wildtype CAP2 (Figure 4A).

CAP2N433

was

more

Since both CAP2N433 and

CAP2AA are missing the potential phosphorylation sites (Ser 433, 434), less
phosphorylation than wild type CAP2 was expected. Perhaps since CAP2N433 is
missing part of the C terminal dimerization domain, this protein is unable to fold
properly and more residues are available for phosphorylation.

By comparing the

amount of phosphorylation of CAP2N304 and CAP2C232, the C terminal of CAP2 is
more phosphorylated than the N terminal. The anti-HA immunoblot indicates that
equal amounts of protein were present in each lane (Figure 4B). Controls for the
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phosphorylation assay include sodium vanadate (NaV 0 4 ) treatment (4C,D) and calf
intestinal alkaline phosphatase (CIAP) treatment (4E,F) of CAP2 transfected
HEK293 cells. The 5d exposure autoradiograph in Figure 4C shows that treatment
with NaV 0 4 increases the amount of phosphorylation, while treatment with CIAP
(Figure 4E) decreases the overall level of phosphorylation. Anti-HA blots in Figure
4D and 4F indicate that similar amounts of protein were present in each lane.

Conserved serines are important fo r actin binding
Post-translational modifications such as phosphorylation are a common mechanism
used to regulate protein function. In order to determine if phosphorylation of CAP2
regulates its actin binding ability, co-immunoprecipitations were performed with wild
type and deletion mutants of CAP2. HEK293 cells were transfected with HA-tagged
CAP2 constructs, and protein extracts were subjected to immunoprecipitation using
anti-HA antibody chemically coupled to protein A beads. Actin binding ability was
determined through western blot analysis with anti-actin and anti-HA antibodies.
CAP2N433 was unable to bind actin while CAP2AA bound significantly less actin in
comparison with wild type CAP2 (Figure 5). Both of these mutants are missing the
two conserved Ser 433 and Ser 434. CAP2N433 is additionally missing part o f the
carboxyl terminal actin-binding domain.

The anti- HA blot (Figure 5B) indicates

that all proteins were immunoprecipitated in comparable amounts.
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Figure 4: CAP2 is a Phosphoprotein. A: Autoradiograph of radiolabelled
immunoprecipitated CAP2 constructs from transfected HEK293s. Band intensity
indicates CAP2 wild type, CAP2N433, and CAP2C232 are highly phosphorylated
while CAP2AA and CAP2N304 are minimally phosphorylated. B: Anti-HA blot of
immunoprecipitation shows that equal amounts of CAP2 were loaded into each lane.
C: In a separate in vivo phosphorylation assay, HEK293 cells transfected with HACAP2 were incubated with sodium vanadate for the final hour of the incubation with
labeled media or left untreated. Untreated CAP2 is less phosphorylated than sodium
vanadate treated CAP2. D: The anti-HA blot of the autoradiograph of 4C
demonstrates that equal amounts of protein were present in each lane. E:
immunoprecipitated radiolabelled CAP2 protein was treated with calf intestinal
phosphatase (CIAP) for 2h at 37°C. A control was incubated without enzyme. The
sample containing CAP2 treated with CIAP displayed significantly less
phosphorylation than the control. F: The anti-HA blot of the autoradiograph in 4E
demonstrates that equal amounts o f protein were present in each lane.
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Figure 5: Effect o f Phosphorylation of CAP2 on Actin Binding. In a duplicate
trial of the phosphorylation assay shown in Figure 4, the blot containing the
radiolabelled proteins was probed for the presence of actin. CAP2 has a strong
interaction with actin while CAP2AA and CAP2C232 are binding minimal actin (A).
No actin binding is seen with CAP2N304. This mutant is lacking the actin binding
domain. Actin binding is not seen with CAP2N433, a mutant that is missing most of
the actin binding domain, serines 433 and 434, and part of the second dimerization
domain. The anti-HA blot that demonstrates that similar amounts of protein were
present in each lane (B).
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CAP2 Phosphorylation is Calcium Independent
Calcium is required for many biological processes such as synaptic transmission and
by several signaling molecules like kinases and phosphatases.

An in vivo

phosphorylation assay was performed in the absence and presence of a divalent cation
chelator EDTA to determine if CAP2 phosphorylation is calcium dependant. The
autoradiograph indicates that there is no significant change in the amount of CAP2
phosphorylation in the presence or absence of calcium (Figure 6A). The anti-HA
immunoblot indicates that equal amounts of protein were present in each lane (Figure
6B). Interestingly the results indicate that actin binding increased was in the presence
of a calcium chelating agent, while the presence o f calcium had no effect on actin
binding (Figure 6C).
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Figure 6: Phosphorylation of CAP2 is Calcium Independent. HEK293 cells
transfected with CAP2 were subjected to an in vivo phosphorylation assay. To
determine the effect of calcium on CAP2 phosphorylation, cells were treated with
CaCl2 alone (Ca +) or CaCl2 with EDTA (Ca-). No significant difference in CAP2
phosphorylation was seen in the presence or absence of calcium (A). The anti-HA
blot indicates that equal amounts of protein were present in each lane (B). The antiHA blot was stripped and reprobed for actin. Actin binding was increased in the
presence of CaCl2 and EDTA (C).
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PKC enhances CAP2 phosphorylation
Kinases have the ability to phosphorylate target proteins. Kinases are often activated
as a part of a signal transduction pathway. Protein Kinase C (PKC) is a very common
kinase that is involved in various signal cascades leading to different intracellular
responses. Protein Kinase A (PKA) is activated downstream of Ras in a pathway
involving CAP in yeast. Rac is a protein that is known to induce changes in the actin
cytoskeleton (Hall, 1998). In order to determine which pathway may lead to
phosphorylation of CAP2, chemical activators of PKA, Rac, and PKC were utilized
(platelet derived growth factor (PDGF), forskolin, and PMA respectively). Serum
starved HEK293 cells expressing CAP2 were incubated with media containing
radiolabelled phosphate for three hours. The chemical activators were added to the
media when one hour of incubation remained. The autoradiograph of the
immunoprecipitated protein is shown in Figure 7A. Activators PDGF and forskolin
caused no significant change in CAP2 phosphorylation. Treatment with PMA
dramatically increased the level of CAP2 phosphorylation. The anti-HA blot
indicates that equal amounts of CAP2 protein was present in each lane (Figure 7B).

Effect o f PKC activation on Actin Binding
Since PKC activation increased CAP2 phosphorylation, and loss of phosphorylation
sites Ser 433 and 434 decreased actin binding, it was questioned whether or not PKC
activation affects CAP2 actin binding. Serum starved HEK293 cells transfected with
HA-CAP2 were exposed to increasing concentrations of the PKC activator PMA
during the incubation with labeled orthophosphate. An increase in phosphorylation of
CAP2 was seen in the PMA treated cells versus untreated cells (Figure 8A). CAP2
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phosphorylation did not increase with increasing concentrations of PKC activator,
PMA. The anti-actin blot indicates that the level of actin binding did not change
significantly with increasing levels of PMA (Figure 8B). The anti-HA blot of equal
amounts of protein extract indicates that similar amounts of CAP2 were used for
immunoprecipation (Figure 8C).
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Figure 7: Effect of Chemical Activators on CAP2 Phosphorylation.
A: Autoradiograph of phosphorylated CAP2.

Transfected HEK293s were serum

starved for 16h prior to 3h incubation with media containing radiolabelled phosphate.
Lane 1 is CAP2 from untreated cells and lane 2 is from serum starved cells. The
following chemical activators were added to the media for the final hour of
incubation: lOuM forskolin (lane 3), 3pM PDGF (lane 4), 2pM PMA (lane5).
Proteins were immunoprecipitated with anti-HA coupled protein A beads, resolved on
an SDS PAGE gel and then transferred to a nitrocellulose membrane to perform
autoradiography. B: Anti-HA immunoblot of the same membrane from 6A.
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65kD

Figure 8: Effect of PKC Activation on Actin Binding. HEK293 cells transfected
with HA-CAP2 exposed to orthophosphate-containing media were incubated with
increasing amounts of PMA (5pM, 3pM, lpM , 0.5pM, 0) in lanes 1-5. Lane 6 is an
untransfected control. The autoradiograph in figure 8A shows an increase in
phosphorylation from wildtype in lane 5 and PMA treated in lane 4. Increasing
concentrations of PMA do not produce a dose-dependant increase in CAP2
phsphorylation. No significant change in actin binding ability of CAP2 is seen (8B).
The anti-HA blot indicates that similar amounts o f CAP2 were used in each
immunoprecipitation (8C).
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Figure 8.
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Further Evidence o f Multiple Phosphorylation Sites
It was clear from the initial phosphorylation assays that CAP2 is phosphorylated on
multiple residues. In order to understand the mechanism of regulation behind CAP2
phosphorylation, the sites of phosphorylation must be determined. Two-dimensional
gel electrophoresis is used to visualize small differences in protein mobility due to
slight changes in isoelectric point (for review (Mann and Jensen, 2003).

The

movement of the protein is based on the overall charge of its side chains and posttranslational modifications.

Small changes in isoelectric point can be caused by

phosphorylation of one or more residues.

A phosphate group is very negatively

charged and alters the overall charge of the protein, therefore changing the mobility
of the protein.

Other post-translation modifications like glycosylation and

ubiquitination are not charged groups are often detected by overall change in the mass
of the protein.
A two-dimensional (2D) gel is performed in two steps.

First, proteins are

separated in one dimension according to their isolectric point and then separated in a
second dimension according to their molecular weight.

In this experiment an

immunoprecipitation was used to isolate the proteins of interest, and 2D gel
electrophoresis was performed to determine if the protein has multiple isoelectric
points.

Since all of the proteins are HA-tagged, CAP2 constructs were visualized

with both anti-CAP2 antibodies and anti-HA antibodies to ensure that spots are
indeed CAP2 protein. Results of 2D analysis showed that CAP2 has four different
forms while CAP2AA appears to only have three (Figure 9). CAP2N304 has four
isoelectric points while CAP2N433 has seven. The untransfected control gels have
no distinct spots, indicating that there were no non-specific proteins binding to the
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protein A beads in the immunoprecipitation. This experiment was performed twice
with identical results.
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Figure 9: Two-dimensional Electrophoresis. Two-dimensional electrophoresis was
used to visualize small differences in isoelectric point of CAP2 protein.
Immunoprecipitated HA-tagged CAP2 constructs (CAP2, CAP2AA, CAP2N433)
were subjected to isoelectric focusing followed by SDS-PAGE gel electrophoresis.
Gels were transferred to nitrocellulose membranes and immunoblotted with anti-HA
(left) and anti-CAP2 (right) antibodies. Untransfected HEK293 cells were used as a
control (UT).
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Discussion

It is known that other actin binding proteins (i.e. WASp) are regulated by
phosphorylation, therefore this suggests that perhaps CAP2 is regulated in a similar
fashion. First, it had to be determined whether CAP2 is phosphorylated in vivo. In
vivo phosphorylation assays revealed that human CAP2 is phosphorylated on
serine(s) 433 and/or 434. These residues are highly conserved in all CAPs identified
to date (see Figure 2).

In fact, CAPs that do not have these two serines have a

threonine residue in place of the serine, so essentially all CAPs have two residues
available for phosphorylation at this site. From this information, it seems possible
that all CAPs are phosphoproteins.
One of the interesting results involved CAP2N433; the mutant is lacking the
two conserved serine residues, the actin binding domain and part of the second
dimerization domain. It is unclear why CAP2N433 would be more phosphorylated
than wild type CAP2 if it were missing the two phosphorylation sites. There are
several explanations for this result.

Perhaps CAP2N433 is folded into a different

conformation because it is truncated and this shape allows more residues to be
phosphorylated. CAP2N433 may not be able to form dimers as well as wild type
CAP2 and this may leave the protein open / unfolded for more residues to become
phosphorylated. Actin binding is decreased in this mutant of CAP2 and perhaps actin
binding decreases phosphorylation.

It is very clear that CAP2 is phosphorylated at

multiple sites because altering the two conserved serines reduced, but did not abolish
phosphorylation of the protein. Comparing the amount of phosphorylation of CAP2N304 with CAP2-C232 indicates additional phosphorylation sites are more likely to
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be in the carboxyl terminus than the amino terminus.

As mentioned earlier,

phosphorylation is often used to regulate proteins involved in signaling cascades.
Phosphorylation by an activated kinase may be activating CAP2 in order to cause
cytoskeletal changes.
Once it was established that CAP2 was phosphorylated, the functional role of
phosphorylation was examined. A two amino acid alteration (CAP2AA) caused a
significant decrease in both phosphorylation and actin binding of CAP2.

This

suggests that this post-translational modification regulates the interaction between
CAP2 and actin. CAP2N433 is further impaired in its ability to bind actin but this is
more likely do to the truncation of its actin-binding domain.
Perhaps CAP2 is phosphorylated in response to a signal to regulate the protein
itself. It was mentioned earlier that CAP shows similarities with WASp, a protein
that is regulated by auto inhibition. W ASp contains two self-interacting domains, as
does human CAP1 and CAP2, that allow for the formation of an auto inhibited loop
(Hubberstey et al., 1996; Pufall and Graves, 2002).

Perhaps full length CAP2 is

present in a looped conformation that blocks phosphorylation sites, but has enhanced
affinity for actin. This suggests that phosphorylation regulates conformation of the
CAP2 protein and then conformation regulates actin-binding function.
The 2D gel blot of CAP2N433 show several more spots than wild type CAP2.
In addition, the CAP2N433 construct was more phosphorylated than wild type CAP2
in the in vivo phosphorylation assay.

Perhaps CAP2 is usually in a folded

conformation that inhibits phosphorylation of several residues but upon truncation of
the actin binding domain the protein is unable to fold properly and several more sites
are phosphorylated.
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Another important question to be answered is which signaling pathways are
responsible for the phosphorylation of CAP2. Several different signaling pathways
result in changes in the actin cytoskeleton. Several potential pathways that could lead
to phosphorylation of CAP2 were examined. In yeast, S. cerevisiae, CAP is involved
in the RAS2 pathway.

Upon activation of the small G protein, RAS2, adenylyl

cyclase (AC) is activated, generating cAMP, which causes a response in cell growth
regulation. CAP is a binding partner of AC and is thought to regulate this pathway.
Protein Kinase A (PKA) is activated downstream of AC in the R A S1 pathway leading
to cytoskeletal changes (Hubberstey and Mottillo, 2002).

The effect of PKA

activation on CAP2 phosphorylation was examined even though mammalian CAPs
have not been shown to be involved in an activated RAS pathway. PKA activation is
known to have a negative affect on axonal transport, a process that requires actin
rearrangement (Hiruma et al., 1999). Another small GTPase, Rac, is known to induce
changes in the actin cytoskeleton and thus was an adequate suspect upstream CAP
signaling protein (Hall, 1998).
In an attempt to examine the potential pathway leading to CAP2
phosphorylation a discovery was made. Treatment of transfected HEK293 cells with
the phorbol ester PMA significantly increased the amount of CAP2 phosphorylation.
These results suggest that a cellular signal causes activation of PKC (activated by
PMA) that leads to direct or indirect phosphorylation of CAP2, which may regulate
its actin binding ability at a site(s) where actin rearrangement is required. This
evidence supports a role for CAP2 as a link between signaling pathway(s) through
PKC and actin rearrangement.
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Calcium is an essential ion within the cells. Calcium is required for many
forms o f signal transduction such as synaptic transmission.

In the calcium

dependency experiment (see Figure 6), EDTA was used to deplete intracellular
calcium.

Levels of phosphorylation of CAP2 did not change in the presence or

absence of calcium. The results of this experiment suggest that phosphorylation of
CAP2 is independent o f calcium but interestingly, actin binding increased in the
absence of calcium.

EDTA is not specific to only calcium ions, it will bind any

divalent cation. Therefore the increase in actin binding of CAP2 that was seen in the
presence of EDTA may be due to a loss in magnesium or another divalent cation.
Depletion of intracellular calcium will have many different effects within a cell such
as reduction in enzyme activity of those enzymes that require calcium in their active
site. A decrease in calcium could have a negative affect on actin polymerization by
destabilizing F-actin. In the presence of a huge excess of monomeric actin, CAP2
may bind more actin than it typically would. The ratio of one CAP2 proteins binding
one actin monomer will not change but the proportion of bound CAP2 versus
unbound CAP2 could increase. This could explain why CAP2 bound significantly
more actin in the presence of EDTA.
There are three classes of PKCs: classical, novel and atypical. Each isoform
has different expression patterns in different tissues of the body. Since this study
indicates that the phosphorylation of CAP2 is calcium independent, the classical
isoforms can be ruled out due to their calcium dependency. The result that CAP2
phosphorylation is calcium independent corroborates previous studies that have
shown that actin binding in Dictyostelium CAP is calcium independent (Gottwald et
al., 1996).
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As mentioned earlier, CAP is a bifunctional protein that has been theorized to
play a role in actin dynamics and endocytosis. The process of endocytosis requires
actin rearrangement.

Yeast synaptobrevin homologue, SNC1, is thought to be

involved in targeting the fusion of synaptic vesicles. SNC1 can suppress C-terminal
deletions of CAP in yeast (Gerst et al., 1991). This suggests a potential role for CAP
in the endocytic process. M uncl8, a syntaxin binding protein, is phosphorylated by
PKC.

Upon modification, syntaxin binding to M uncl8 is reduced.

This allows

syntaxin to form the snare complex essential to endocytosis/vesicle fusion (Barclay et
al., 2003).

As mentioned earlier, PKC has been shown to play a role in actin

remodeling in nerve cell and macrophages (Baron et al., 1998; Larsen et al., 2002).
Perhaps upon activation by phosphorylation by PKC, CAP2 is delivering actin
monomers to sites of actin rearrangement. PKC also phosphorylates SNAP 25 and
synaptotagmin I, other endocytic proteins (Hilfiker et al., 1999; Iwasaki et al., 2000).
Further studies must be performed to elucidate the pathway through which
PKC is activating CAP2 phosphorylation.

Auto inhibition of CAP, through its

dimerization domains, should be examined with respect to phosphorylation and actin
binding. This study sheds some light on the potential regulatory mechanisms that
control CAP2 function, but more data is required to fully elucidate the role of
phosphorylation of CAP2. The fact that CAP2 is phosphorylated and that PKC is
playing a role, reinforces the theory that CAP2 links actin dynamics to signaling
events.
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CHAPTER THREE
Human CAP2 Localizes to Areas of Actin Rearrangement

Introduction
One of the main objectives of this thesis was to examine the localization of human
CAP2 in mammalian cells. Mouse fibroblasts transiently transfected with MYC-tagged
mouse CAP1 (m C A Pl) indicate that m CA Pl is a cytosolic protein that can localize to the
leading edge of migrating cells (Vojtek and Cooper, 1993).

Endogenous rat CAP1

shows a similar expression pattern (Zelicof et al., 1996). Dictyostelium CAP is cytosolic
with distinct membrane localization that requires the N terminal 102 residues (Noegel et
al., 1999). Human CAP1 was transiently transfected into Swiss 3T3 cells and was shown
to localize to F-actin stress fibers and lamellipodia (Freeman and Field, 2000).
amino terminal domain of hC A Pl was required for this specific expression.

The
In the

absence of the amino terminus, hC A Pl is diffusely cytoplasmic. Recently, endogenous
mCAPl was found to colocalize with actin and cofilin at the leading edge of migrating
mouse C3H-2K fibroblasts (Moriyama and Yahara, 2002).

Cofilin is involved in

cytoskeletal dynamics through its ability to depolymerize F-actin (Carlier et al., 1997;
Rosenblatt et al., 1997).

Human CAP1 and CAP2 protein may not exhibit the same

localization within mammalian cells due to their differential mRNA expression patterns
in rat cells (Swiston et al., 1995).
The

previous

chapter

demonstrated

PKC

may

play

a

role

in

CAP2

phosphorylation. This result may lead to a better understanding of CAP2 regulation. If
phosphorylation regulates a function of CAP2, then perhaps PKC activation will affect
CAP2 localization or its activity with the actin cytoskeleton.

Activation of PKC, by
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PMA, in primary rat brain cells caused phosphorylation of MARCKS (myristoylated
alanine rich C-kinase substrate) and caused cytoskeletal rearrangement (Baron et al.,
1999). PKC is naturally activated when an agonist binds a cellular receptor that causes
increased production of diacylglycerol. PMA is able to activate PKC by being a DAG
mimic. PMA is a more stable compound than the membrane permeable DAGs, therefore
PMA is a more potent PKC activator (Nishizuka, 1992). PKC also plays a role in the
rearrangement of F-actin during phagocytosis and phagosomal maturation (Holm et al.,
2003).

Another PKC substrate called Clone 72, relocalizes to lamellipodia upon

phosphorylation, suggesting that PKC is involved in cytoskeletal remodeling (Chapline et
al., 1998).

PKC activation via PMA in rat oligodendrocyte progenitor cells causes

cytoskeletal rearrangement that prevent differentiation (Baron et al.,
macrophages

PKCe

overexpression

can

enhance

actin

1998). In

polymerization

during

phagocytosis (Larsen et al., 2002).
Subcellular fractionation of HEK293 cells transfected with CAP2 displays that
this protein is mainly cytosolic with some membrane localization.

This result was

verified in REF52 cells that displayed endogenous CAP2 as a cytosolic protein with some
perinuclear localization. Wound assays were performed on REF52 cells to create sites of
actin remodeling. Upon wounding, CAP2 localizes to the leading edge of REF52s where
actin is being rearranged. In a separate experiment REF52 cells were treated with PMA,
a PKC activator previously shown to increase CAP2 phosphorylation.

Upon PKC

activation, cytoskeletal abnormalities appeared and CAP2 was localized to these F-actin
containing structures. This confirms that PKC activation by PMA can result in actin
rearrangement and suggests that CAP2 is playing a role in this process.
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Material and Methods

Subcellular Fractionation
HEK293 cells on 100mm plates were transfected with 8pg pCI-HA-Scythe-313, pCI-HACAP2, or no vector, using lOpl Lipofectamine 2000 (Invitrogen/Life Technologies),
according to manufacturers directions. At 48h post-transfection, cells were collected in
500pl RIPA buffer [20mM Tris pH 7.5, 150mM NaCl, lOmM KC1, 1% IGEPAL CA-630
(NP-40), 10% glycerol, and protease inhibitor cocktail (complete Mini, Roche)]. Prior to
differential centrifugation, cells were homogenized on ice in a 1mL Dounce homogenizer
with 50 strokes. The method used was modified from Shi et. al. 1996. Briefly, cell
extracts were spun at 1500g for 8m to obtain the nuclear pellet and the first supernatant
(SI). SI was spun at 100,000g for 90m at 4°C to obtain the membrane pellet and the
second supernatant is the cytosolic fraction.

Nuclear and membrane pellets were

resuspended in 500pl STE buffer [0.25M sucrose, lOmM Tris pH 7.5, ImM EDTA pH
7.4, protease inhibitor cocktail].

Equivalent amounts of each protein fraction were

electrophoresed on a SDS-PAGE gel and transferred to a nitrocellulose membrane for
immunoblotting. After blocking over-night in 2% skim milk in TBS the blot was probed
with

12CA5 (anti-HA) antibodies followed by anti-mouse secondary antibodies

conjugated with horseradish peroxidase.

Bands were visualized using Lumi Light

Chemiluminesence kit (Roche).

Immunocytochemistry
To visualize endogenous CAP2, confluent REF52 cells on glass coverslips were fixed in
3.7% formaldehyde, permeabilized in 0.5% Trition X-100 and probed with rabbit
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polyclonal anti-CAP2 antibodies (1:40) followed by fluorophore labeled secondary
antibody goat anti-rabbit IgG Alexa 488 (1:10,000).
For wound assays, REF52 cells were grown on glass coverslips until 90%
confluent.

Media was removed and cells were scored with a rubber policeman.

Coverslips were fixed and processed for CAP2 and actin expression at 0m, 10m, 30m, 2h,
3h, and 6h post-wounding.

Cells were probed with anti-CAP2 rabbit polyclonal

antibody, fluorophore labeled goat anti-rabbit IgG Alexa 488 (Molecular Probes), and
Alexa 568 phalloidin (l:10000)(M olecular Probes). Cells were viewed with a Bio-Rad
1024 confocal microscope; images were collected using Biorad software, then processed
using Confocal Assistant and Corel Draw 9.
For chemical effect assays, REF52 cells were grown on coverslips, serum starved
for 16h, then treated with PMA at increasing concentrations for different time intervals.
Coverslips were removed at various time intervals and processed for CAP2 or actin
expression as described above.

Results

CAP2 is a cytosolic protein
CAPs have been previously demonstrated to be cytoplasmic proteins that can bind
monomeric actin, however the localization of human CAP2 has never been described
(Freeman and Field, 2000; Freeman et al., 1996; Gottwald et al., 1996; Vojtek and
Cooper, 1993). REF52 fibroblasts were stained with an antibody raised against human
CAP2.

Localization of CAP2 was diffusely cytoplasmic with some perinuclear
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localization (Figure 10A). This expression pattern supports the role of CAP2 in actin
cytoskeletal dynamics as both forms of actin are known to be found within the cytoplasm.
Since human CAP1 has been implicated in vesicle trafficking and endocytosis, the
subcellular localization of CAP2 was examined. HEK293 cells overexpressing CAP2
were separated into cytoplasmic, nuclear and membrane fractions.

CAP2 was found

within the cytoplasmic fraction but some was found in the membrane fraction (Figure
10B).

CAP2 is localized to areas o f actin rearrangement
CAP1 localizes to stress fibers in REF52 fibroblasts and lamellipodia in Swiss 3T3
fibroblasts (Freeman and Field, 2000).

Mouse actin-binding protein 1 (m A bpl) also

localizes to sites of cell migration and has been suggested as a potential binding partner
of yeast CAP (Srv2) (Freeman et al., 1996; Lila and Drubin, 1997). This interaction
suggests that CAP2 may have a role in regulating actin treadmilling in mammalian cells.
In order to determine the legitimacy for this role, wounding assays were performed on
REF52 fibroblasts. REF52 cells were chosen because they express a large amount of
endogenous CAP2 (Figure 10A). A confluent monolayer of REF52 cells was cut and
cells were allowed to migrate into the wound.

At the edge of this cut the cells are

actively moving into the wound to repair the wound. At the migrating edge actin is being
remodeled and monomeric actin is being delivered at a rapid rate that cannot be explained
by simple diffusion (Zicha et al., 2003). As early as 30 minutes after wounding, CAP2
expression is intensified at the cut edge of REF52 fibroblasts (Figure 11B).

CAP2

remains localized to the leading edge up to 4 hours post wounding (Figure 11C-E). This
phenomenon dissipates by 6 hours after wounding when the cells are nearly finished
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closing the wound (Figure 11F). It was noticed that filamentous actin disappears from
the edge of cells once they began migrating, while CAP2 expression increased at the cell
edge (compare Figure 11A and B). This suggests that F-actin is being depolymerized
into G-actin (G-actin is not stained by phalloidin) so that the cytoskeleton can be
remodeled to migrate into the wound.

Actin treadmilling involves removal of actin

monomers from the growing end of the actin filament and addition of actin monomers to
the opposite end of the filament to push the filament forward to generate the locomotion
of the leading edge of the cell. Perhaps CAP2 is releasing actin monomers at this site of
actin rearrangement to encourage forward outgrowth. It was recently shown in tobacco
suspension culture cells that overexpresion of AtCAPl (Arabadopsis) causes decreased
leaf size due to loss of F-actin (Barrero et al., 2003). This result reinforces the theory that
CAP2 is involved in actin dynamics.
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Figure 10 : CAP2 localization.
grown to 80% confluency.
polyclonal antibodies.

REF52 cells were plated onto glass coverslips and

Cells were fixed and then probed with rabbit anti-CAP2

Secondary fluorophore labeled goat anti-rabbit IgG antibodies

were used to visualize endogenous CAP2 protein. CAP2 is a cytosolic protein with some
perinuclear localization (A). Subcellular fractionation of transfected HEK293 cells was
performed to verify CAP2 localization. Nuclear (N), cytosolic (C), and membrane (M)
fractions were collect via differential centrifugation.

CAP2 is present mainly in the

cytsolic fraction but also in the membrane fraction.
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Figure 11: CAP2 localizes to the leading edge of fibroblasts. REF52 fibroblasts
expressing endogenous CAP2 were seeded onto glass cover slips and grown to 90%
confluency.

Cells were wounded and then allowed to heal.

Cover slips were

removed and processed for CAP2 and actin expression at 30m(B), lh(C ), 2h(D),
4h(E), 6h(F), or untreated (A).

CAP2 localization is initially cytoplasmic on the

unwounded cover slip (A). As soon as 30m after wound CAP2 relocalizes to the
leading edge of the migrating cells (B-E). CAP2 expression is intense in the tips of
the lamellipodial extensions (C, E). CAP2 localization returns to cytoplasmic 6h after
wounding (F).
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PKC activation induces cytoskeletal changes and relocalization o f CAP2
REF52 fibroblasts were treated with various chemical activators in order to identify the
signaling pathway that may regulate CAP2 activity. Cells were serum starved to deplete
the media of any growth factors that may interfere with or mimic the effect of the
activating agents the cells were being incubated with post-starvation. The phorbol ester
PMA, an activator of PKC, produced the most significant results while forskolin,
staurosporine did not create any noticeable effect (data not shown).

It is known that

PMA treatment induces actin reorganization (Hedberg et al., 1994). PKC is required for
several actin-dependant processes including proper axonal transport, neurite outgrowth,
and repair (Hiruma et al., 1999). It is not surprising that PKC, a kinase with various
cytoskeletal effects, causes changes in the localization of CAP2, a cytoskeletal regulator
since PKCa is relocalized to the leading edge of cells migrating into a wound (Liao and
Jaken, 1993).
Untreated REF52 cells contain CAP2 in cytosolic localization that was verified through
subcellular fractionation (Figure 10B).

Upon treatment of REF52s with PMA,

cytoskeletal changes are visible. Lamellipodial extensions are seen at the edge o f the cell
after lh incubation with IOjjM PMA (Figure 12B and C).
intensified within the tips of these lamellipodia.

CAP2 expression is

F-actin is present within these

lamellipodial extensions that are generated upon PKC activation (Figure 13B-D).

It

seems that PKC activation induces cytoskeletal rearrangement at the cell’s periphery,
quite similar to the wounding response described earlier.
PKC, CAP2 relocalizes to actin containing structures.

Clearly, upon activation of
This suggests that CAP2 is

involved in actin remodeling and that PKC activation induces this response.
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Figure 12: Effect of PKC activator, PMA, on endogenous CAP2.

REF52

fibroblasts were serum starved for 16h prior to treatment with DMSO (A), 10pm
PMA (B and C), or 20 pM PMA (D). Cover slips were removed at time intervals and
processed for endogenous CAP2 localization after 1 hour (A-C) or 6 hours (D) of
treatment.

Treatment with PKC activator PMA induces the formation of

lamellipodial extensions that are rich in CAP2.

67

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

A

B

C

D

Figure 12.

68

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 13: F-actin is localized to lamellipodial extensions in response to PKC
activation.

Seram starved REF52 fibroblasts were treated with OuM (A), IO11M

(B,C) or 20pM (D) PMA for lh (A,B) or 6h (C,D).

Coverslips were fixed and

stained with phalloidin to reveal F-actin localization. Cells treated with PMA, a PKC
activator, form lamellipodial extensions at the cell periphery (B-D) while untreated
cells do not (A). F-actin is localized within the lamellipodial extensions.
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Discussion
Eukaryotic CAPs are highly conserved actin binding proteins that have been
shown to play regulatory roles in cell elongation, cytokinesis, cell migration and polarity,
and axon pathfinding in non-vertebrate species (Bahn and Sundstrom, 2001; Barrero et
al., 2002; Benlali et al., 2000; Kawai et al., 1998; Noegel et al., 1999; Wills et al., 2002).
Two CAP homologs have been identified in all vertebrates studied including mouse, rat
and human (Matviw et al., 1992; Swiston et al., 1995; Vojtek and Cooper, 1993). Even
though hCA Pl and hCAP2 share 64% amino acid homology most studies have focused
on CAP1 and little information exists about the function of CAP2. Although there are
differences in the mRNA expression of these two genes in rat, it is not clear if there are
functional differences (Swiston et al., 1995).
This chapter describes the localization of CAP2 in HEK293 cells and REF52
fibroblasts.

It is essential to have data including endogenously expressed proteins to

ensure that the observed effects are valid and not the result of hyperactivity of an
overexpression system.

Subcellular fractionation of transfected HEK293 cells found

CAP2 exists primarily as a cytosolic protein with some membrane affinity, not unlike
CAP1. Endogenous CAP2 expression in REF52s is cytoplasmic with some perinuclear
localization. Interestingly, CAP2 appears to specifically alter its localization in response
to environmental cues. Upon cell wounding, CAP2 localizes to the leading edge of the
migrating cell within lamellipodial extensions.
pattern of localization (Kessels et al., 2000).
dynamic actin rearrangement.

Mouse A bpl also displays a similar
The leading edge of a cell is a site of

These results suggest a role for CAP2 in cytoskeletal

growth through its ability to bind actin monomers and perhaps release them at sites of
actin rearrangement.
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Treatment of REF52s with PMA also caused relocalization of CAP2. After 1 hour of
treatment with PMA, lamellipodial extensions were generated and CAP2 was intensely
expressed within them.
lamellipodia.

It was also demonstrated that F-actin is present within the

Growth factors have been shown to be able to induce lamellipodia

formation and in COS cells mAbpl localizes to these extensions (Kessels et al., 2000).
Similar lamellipodial extensions have been observed in gastric fibroblasts in response to
PMA treatment (Chew et al., 2002). The data presented in this chapter places CAP2 and
F-actin together at the cell periphery where actin remodeling is occurring in response to
PKC activator by PMA. These results suggest CAP2 is involved in a signal transduction
pathway downstream of PKC and may be involved in sequestering and releasing actin
monmers during PMA activated signal transduction at sites of high actin turnover. The
presence of CAP2 in dynamic regions at the cell periphery is consistent with its possible
involvement in actin treadmilling or G-actin sequestering (Freeman et al., 1995;
Gieselmann and Mann, 1992; Gottwald et al., 1996; Moriyama and Yahara, 2002).
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CHAPTER 4
Conclusions and Future Prospects

General Conclusions
The goal of this thesis was to gain a better understanding of the regulation of
mammalian CAP proteins. Studies in yeast have revealed that yeast CAP is involved in
an activated Ras2 pathway that leads to the induction of adenylyl cyclase. In mammalian
cells, CAP homologues contain a conserved adenylyl cyclase binding domain but have
not been demonstrated to interact with adenylyl cyclase. Since yeast CAP interacts with
adenylyl cyclase and vertebrate CAPs do not, it is thought that a different mechanism and
/ or an alternate signaling pathway might regulate vertebrate CAPs.
In this study, human CAP2 was determined to be a phosphoprotein through the
use of in vivo phosphorylation assays. Two likely phosphorylation sites were mapped to
conserved serines 433 and 434.

Two-dimensional electrophoresis demonstrated that

additional sites of phosphorylation exist within the carboxyl terminus of CAP2.
Chemical activators of various signaling pathways were tested for their ability to alter the
phosphorylation of CAP2.

Activation of PKC, by PMA, was able to increase

phosphorylation of CAP2 significantly, in a calcium independent manner. This result
indicates that CAP2 is a downstream target of PKC.
The effect of phosphorylation on the ability o f CAP2 to bind actin was studied. A
mutant with two conserved serine residues (433, 434) altered to alanine (CAP2AA)
displayed reduced levels of phosphorylation and also had reduced actin binding. This
result suggests phosphorylation of CAP2 on serines 433 and 434 positively regulates
actin binding. Another mutant of CAP2 missing both conserved serine residues as well
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as the carboxyl terminal actin-binding domain (CAP2 N433) had increased levels of
phosphorylation.

This result was quite unexpected but can be explained through the

concept o f autoinhibition.

Some proteins, like WASp, have a folded or inhibited

conformation as well as an unfolded conformation.

Perhaps the truncation of the

carboxyl terminus in the CAP2N433 mutant prevents the formation o f a folded
conformation.

This permanently unfolded protein may have more sites that are now

accessible for phosphorylation.

CAP2N433 is also missing the second dimerization

domain. Perhaps CAP2 exists in a dimeric form, concealing phosphorylation sites and
without this domain CAP2N433 cannot dimerize to prevent phosphorylation.
Further studies were performed to examine the localization of endogenous and
overexpressed CAP2 in a cell culture system. Endogenous CAP2 in REF52 cells is a
cytosolic protein with some perinuclear localization.

Subcellular fractionation of

transfected HEK293 cells also indicated CAP2 is a cytosolic protein with some
membrane localization, like its homolog CAP1.

In order to further understand the role

of CAP2 within the cell, wounding assays were performed.

CAP2 was intensely

localized to areas of actin remodeling within 30 minutes after wounding. This indicates
that CAP2, a monomeric actin binding protein, is playing a role in the reorganization of
the actin cytoskeleton.

This also indicates that CAP2 is able to rapidly alter its

localization perhaps in response to activation by a PKC predicted pathway.

CAP2

localization was also able to change in response to PKC activation by PMA. Treatment
o f REF52 with PMA caused the formation of lamellipodial extensions of the cytoskeleton
and CAP2 was localized within these structures. PKC activation is known to induce
cytoskeletal effects but since CAP2 expression also changed in response, this further
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reinforces the concept of CAP2 being activated in a signaling pathway downstream of
PKC.

Future Experiments

Phosphorylation Experiments
The results presented in this thesis demonstrate that CAP2 is a phosphoprotein.
Further experiments need to be performed to map all phosphorylation sites of CAP2 and
CAP1.

There are several methods that can be used to perform this task including

phosphoamino acid analysis (PAA) and mass spectroscopy (MS).

PAA should be

attempted first as it is the more inexpensive of the two methods. This method relies on
the fact that phosphorylated serine, threonine, and tyrosine residues are stable in acidic
conditions that can cleave peptide bonds. After acid hydrolysis of the protein of interest
the peptides can be separated two dimensionally by thin-layer chromatography (Zhou et
al., 2001). Phosphorylated residues within the peptides are detected by autoradiography
(if 32P-labelled) and with ninhydrin (visible dye binds alpha amino acids). Phosphoamino
standards are run concurrently with the target sample for comparison.
Matrix Assisted Laser Desorption Ionization- Time of Flight (MALDI-TOF) MS is
designed to examine proteins from smaller than 15 kD. Initially, the protein of interest
will be split into two aliquots and subjected to proteolytic digest with acid, to generate
small peptide fragments.

One group of fragments is treated with calf intestinal

phosphatase to remove phosphate groups from phosphorylated residues while the other
sample is untreated. The peptides are then mixed with a matrix material and deposited
onto a grid or chip. Pulses of laser light ionize the peptides allowing them to enter into
the gaseous phase. These ionized peptides are accelerated in an electrostatic field. All
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particles have the same kinetic energy but lighter ions travel faster and therefore will
reach the detector faster. Ions are detected in a time dependant manner and are analyzed
by measuring their mass to charge ratio. A computer computes the mass spectra and the
peptide fragments are assigned weights. There are online databases containing actual and
expected peptide fragment weights of many proteins. Detection of phosphorylation sites
is done by comparison of the fragments from the phosphatase treated sample with the
untreated sample. If a fragment within the untreated group weighs 80 Da (or a multiple
of 80) more than the same peptide that was exposed to phosphatase, a phosphorylation
site has been identified (for an example see (Vacratsis et al., 2002).
Since PKC activation increases the phosphorylation of CAP2, PMA treatment
would aid in these methods of detecting phosphorylation sites. Only a small percentage
of the protein sample will be endogenously phosphorylated without activation. It would
be interesting to determine if these sites are conserved in CAPs of other species. Sitedirected mutagenesis could be performed to generate mutant forms of CAP2 that cannot
be phosphorylated (change S, T, or Y to A) or are phosphomimicking mutants (change S,
T or Y to D or E). These mutants could be used in an in vivo phosphorylation assay to
further understand the role of phosphorylation in the regulation of CAP function.

Signaling
Research presented in this thesis supports the theory that CAP2 may act as a link
between signaling molecules and cytoskeletal dynamics.

CAP2 phosphorylation is

increased by PKC through activation by PMA, a phorbol ester. While it is known that
32

phorbol esters increase the incorporation of ~ P 0 4 into PKC substrates, it is known that
PKC activation can lead to the activation of other kinases (Chapline et al., 1998). In order
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to determine if CAP2 is directly phosphorylated by PKC, in vitro kinase assays can be
performed to verify CAP2 is a PKC substrate. All other phosphorylation sites must be
mapped and mutants must be generated with alanine substitutions, as was performed for
the CAP2AA mutant, so that each individual site can be tested for phosphorylation by
PKC.
There are numerous isoforms of PKC, so it should be deduced which one is
involved in the pathway leading to CAP2 phosphorylation.

REF52 cells express

isoforms, a, 8, and e while HEK293 cells express a, 5, s, i, and X (Farshori et al., 2003;
Liao and Jaken, 1993). Only three isoforms are common to both cell types used in this
thesis and only two of these are calcium independent, 8 and e. Using antibodies against
these forms of PKC their presence in REF52 and HEK293 cells should be verified. An
immunoprecipitation of CAP2 could be probed for PKC 8 and e using isoform specific
antibodies. If the kinase acts upstream of CAP2 or the interaction o f PKC with CAP2 is
transient, this experiment is unlikely to produce a positive results. Alternatively an in
vitro kinase assay may be performed to see if either PKC 8 or e can cause incorporation
of radiolabelled

32

P 0 4 from ATP into CAP2.

The three small GTPases, Rac, Rho, and Cdc42, of the Rho family are often
involved in cytoskeletal signaling. Constitutively active and dominant negative forms of
these GTPases can be used in a phosphorylation assay to determine if they are involved
in CAP2 phosphorylation. These constructs may also be transfected into REF52s to see
if they alter endogenous CAP2 localization. Rho is the most likely of the three GTPases
to be involved in CAP signaling because of its role with cofilin, another cytoskeletal
protein.

Rho activates the Rho associated kinases PAK and ROCK, which in turn

activate LIM kinase (LIMK) (Ohashi et al., 2000a; Ohashi et al., 2000b).

LIMK
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inactivates cofilin by phosphorylation.

Cofilin prevents the formation of F-actin by

causing fragmentation of F-actin filaments (Ohashi et al., 2000a). It is thought that CAP2
and cofilin may work together to disassemble F-actin into G-actin monomers at sites of
actin remodeling.

To determine the affect o f Rho on CAP2, REF52 cells could be

transfected with Rho sense and antisense oligonucleotides (RNAi).

Since Rho is an

important cytoskeletal signaling molecule, both experiments should cause cytoskeletal
changes, as Rho expression will be either upregulated (sense), or knocked down
(antisense).

CAP2 localization should not be affected unless CAP2 is a downstream

effector of Rho.
CAP2 has several conserved domains that could allow it to serve as an adaptor
molecule between signaling cascades and actin rearrangement. CAP2 is able to sequester
monomeric G-actin and can interact with other proteins via its amino terminal coiled-coil
domain, its central poly-proline region or perhaps through dimerization with other
proteins using its two dimerization domains.

A recent report has found rat CAP2 in

circumvallate papillae where it is thought to be involved in taste transduction (Ishimaru et
al., 2001).

CAP function
Perhaps the most interesting discovery made in this thesis was that decreased
phosphorylation of CAP2 was correlated with reduced actin binding.

It would be

interesting to see if over-expression of CAP2AA in REF52 cells causes any cytoskeletal
abnormalities like impaired migratory abilities or lack of lamellipodial extensions in
response to PMA treatment.

These

results would reinforce the theory that
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phosphorylation of conserved serine residues 433 and 434 of CAP2 is essential to cell
migration and that PKC is responsible for the phosphorylation of these residues.
In order to learn more about the role of CAPs with the actin cytoskeleton, CAP2
expression can be repressed through RNA inhibition technology (RNAi).

Reducing

levels of profilin, another actin binding protein, was achieved by perfusing smooth
muscle tissue with antisense oligonucleotides (Tang and Tan, 2003). This experiment
demonstrated that the absence of profilin caused a reduction in force development.
Megakaryocytes treated with WASp antisense causes dysfunction in vesicle formation
and F-actin bundling (Miki et al., 1997). If CAP2 RNAi can prevent CAP2 relocalization
and formation of lamellipodial extensions than it is clear that CAP2 is regulating the
cell’s migratory response.

It may be necessary to use RNAi against both CAP1 and

CAP2 simultaneously to see a cellular response as these two homologs may play a
redundant role. REF52 could be further fractionated to isolate a lamellipodial fraction to
verify CAP2 localization to the leading edge during cell migration (Kessels et al., 2000).
To investigate how CAP2 interacts with other proteins to perform cytoskeletal or
signaling functions, interacting partners must be identified. There are several ways to
perform this search. Previously our lab performed a yeast two-hybrid screen of a brain
cDNA library and found a neuronal binding partner for CAP1 and CAP2 named neuronal
calcium binding protein (NECAB) (Motillo et. al. submitted 2003). MS can be used to
search for interacting proteins after a sensitive immunoprecipitation (IP) has been
performed. The IP should be performed using endogenous CAP2 either from rat brain or
REF52 cells. The immunoprecipitated proteins can be directly acid-hydrolyzed and sent
for mass finger printing or two-dimensional (2D) electrophoresis can be performed.
Two-dimensional electrophoresis will separate proteins by charge and mass into protein
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spots visualized via silver staining. Protein spots can then be cut out and sent for mass
fingerprinting.

A similar experiment was performed on a CAP2 IP but the MS was

unsuccessful as the samples were contaminated. Another experiment, albeit expensive,
is to electroblot the 2D gel before silver staining and send it to BD Transduction Labs for
power blotting. This company will probe your blot with hundreds of antibodies to detect
the proteins creating the spots on the 2D gel.

Autoinhibition
Two-dimensional gels (2D gels) can be used to distinguish between multiple
phosphorylated forms of a single protein. More than one phosphorylated form of CAP2
was expected since alteration of two potential phosphorylation sites (Ser 433,434) to
alanine did not completely abolish phosphorylation of CAP2.

On a 2D gel CAP2

presented three spots while CAP2AA displayed only two. This is readily explained by
the loss of two potential phosphorylation sites in the CAP2AA mutant.

However,

CAP2N433, a mutant missing Ser 433 and 434 presented seven spots on a 2D gel. This
result correlated with the increased level of phosphorylation displayed by CAP2N433 in
the in vivo phosphorylation assays.

CAP2N433 is missing the C terminal forty-one

amino acids. This deleted fragment contains the actin binding domain, a dimerization
domain, and as mentioned, two highly conserved serine residues.

It has been

demonstrated that CAP2N433 is unable to bind actin, but it has not been determined if
CAP2N433 can bind itself or wild type CAP2.

Perhaps CAP2 phosphorylation is

regulated by autoinhibition. CAP2 could generate an inhibited or folded conformation
via an intramolecular interaction using its two dimerization domains. If this theory is
assumed, CAP2N433 could not form the folded conformation and it is likely that more
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residues are available for phosphorylation in this conformation (Figure 14).

This

suggests CAP2 is mostly present in a folded conformation, as the level of
phosphorylation of wild type CAP2 was lower than that of CAP2N433.

Other

cytoskeletal proteins like WASp and PAK are maintained in an inhibited form.
This theory of autoinhibition needs to be examined further. NMR spectroscopy
and X-ray crystallography are the best way to visualize conformational changes that
could inhibit activity like actin binding. Unfortunately a full length crystal of CAP2 has
not been made and it an unlikely prospect as only pieces of the N and C terminal domains
have been successfully isolated (Hofmann et al., 2002; Ksiazek et al., 2003; Rehm et al.,
2002).

Another way to determine which regions of the protein are participating in

autoinhibition is to map the minimal region required for actin binding or a particular
protein interaction. This can be accomplished via cloning or partial proteolysis followed
by functional pull-down assays (Pufall and Graves, 2002). The intramolecular bonds that
hold the inhibited or bent conformation in place need to be mapped and disrupted. In the
case of CAPs disruption of the dimerization domains may prevent dimerization.

The

results of these experiments should provide a clearer picture of how CAP regulates its
ability to bind actin. Furthermore, an analysis of whether phosphorylation affects protein
folding can be performed.
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Figure 14: A model of CAP2 autoinhibtion. CAP2 contains two dimerization domains,
D1 and D2 depicted in A.

Perhaps CAP2 can form an inhibited conformation by

interacting with itself via dimerization domains one and two, as shown in figure B. If
CAP2 is truncated losing the ABD (actin binding domain) and part of D2 then it cannot
form this intramolecular interaction and more residues are available for phosphorylation.
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Endocytic Function
A recent publication displayed a computational strategy for analyzing proteinprotein interactions. Within a complex chart of over 233 interactions Srv2 (yeast CAP)
was associated with A bpl, actin regulating kinase 1 (A rkl), and Protein Kinase C
Related Kinase 1 (Prkl) (Tong et al., 2002). These associations are suggestive of a role
for CAPs in endocytosis. This specific role was not examined in this thesis but perhaps a
future project may explore. The SH3 region of A bpl is able to interact with the poly
proline region o f Srv2, suggesting a role for CAP in signaling (Fazi et al., 2002). Abpl is
also able to interact with two serine/threonine kinases, Prkl and A rk l, via its SH3
domain (Fazi et al., 2002). Prkl has been shown to phosphorylate Panl and prevent the
formation of a protein complex that is required for endocytosis, therefore Prkl is a
negative regulator of endocytosis (Tang et al., 2000; Zeng et al., 2001). This suggests
that A bpl regulates endocytic function through protein-protein interactions via its SH3
domain. Since A bpl interacts with Srv2, perhaps Srv2 is also regulating endocytosis. It
would be interesting to see is Prkl and A rkl could phosphorylate Srv2. If this event is
possible, does it negatively effect endocytosis, prevent a complex formation of Srv2 with
other endocytic proteins, or even have an effect on cytoskeletal dynamics? The role of
Srv2 in endocytosis is further reinforced by the synthetic lethality of Srv2 with Sla2
(Wesp et al., 1997). Sla2 and Prkl are synthetic lethal with A bpl and therefore these
proteins share a redundant role (Fazi et al., 2002). It is intuitive that CAP is involved in
endocytosis as membrane vesicle attachment and release requires actin rearrangement
and CAP is known to localize to such areas (Vojtek and Cooper, 1993).
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APPENDIX A: Oligonucleotides Used

Number

Name

Sequence (5’ -> 3’)

31

lexcap2-f

ttgaattcatggccaacatgcagggactgg

32

lexcap2-r

ttctcgagttaggccataatttctgcagg

108

hacap2c232-f

ttgaattccttttcgagaatgaagcaaaaaaag

109

hacap2n304-r

ttctcgagttaggtgggagattgagtttgccc

161

hancap2433-r

ttctcgagttacacgatctcacagtctaatgc

157

cap2437438aa-f

gagatcgtgagcgccaaggcagctgaaatgaacatacttatc

158

cap2437438aa-r

gataagtatgttcatttcagctgccttggcgctcacgatctc
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N ecabl: a novel human neuronal protein that interacts with Cyclase Associated
Proteins (CAPs) E.P. Mottillo, J.M. Sullivan, V. Patel, W. Lepeak, L.A. Elferink,
A.V. Hubberstey.
M aster’s Thesis
Functional Characterization o f Human CAP2
Honor’s Thesis
Characterization o f Human Necabl
Manuscripts in Submission
Sullivan, J., Mottillo, E.P. and A.V. Hubberstey. (2003) Human CAP2 is a
cytoplasmic phosphoprotein that concentrates at sites o f actin rearrangement in
lamellipodia. J. Cell Science
Manuscripts in Preparation
Mottillo, E.P., Sullivan, J., Patel, V., Lepeak, W., Elferink, L.A. and A.V.
Hubberstey. (2003) N ecabl: a novel human neuronal protein that interacts with
Cyclase Associated Proteins. J. Cell. Biochem.
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